Passive

(redirected from passive immunity)
Also found in: Dictionary, Thesaurus, Medical, Legal, Encyclopedia, Wikipedia.
Related to passive immunity: innate immunity, artificial passive immunity

Passive

Income or loss from business activities in which a person does not materially participate, such as a limited partnership.

Passive

Income (or loss) from an investment in which an individual does not directly participate. The most common types of passive income are rents from property one owns and income from a limited partnership. Some analysts consider income from dividends and coupons to be passive income while others do not. Passive income is taxable, but it is often treated differently from active income.
References in periodicals archive ?
The Cedars-Sinai survey points up one potentially fruitful avenue: improved physician understanding that maternal vaccination provides neonatal protection through passive immunity.
In bovine colostrum, the immunoglobulin antibodies provide a major antimicrobial effect against a wide range of microbes and confer a passive immunity until the calf's own immune system has matured.
Passive immunity to Yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide.
GalaGen's proprietary immunization technology uses immune system stimulating antigens and adjuvants to produce concentrated pathogen-specific polyclonal antibodies which provide passive immunity against disease causing organisms such as C.
13, 2015 /PRNewswire/ -- Moderna Therapeutics today announced a license and collaboration agreement with Merck, known as MSD outside the United States and Canada, through a subsidiary, for the discovery and development of vaccines and passive immunity treatments against viral diseases using modified messenger RNA (mRNA).
Mr Lloyd also stressed that farmers should ensure that every lamb receives sufficient colostrum in the first 4-6 hours of life for its nutritional and laxative as well as passive immunity value.
Behringwerke's vaccine products have their roots in the pioneering work of its founder, Emil von Behring, who received the first Nobel Prize in medicine, in 1901, for his discovery of passive immunity, which led to the development and large-scale manufacture of diphtheria antisera and the diphtheria vaccine.
Moderna venture to advance mRNA vaccines and mRNA-based passive immunity therapies

Full browser ?